Akebia Therapeutics
AKBA
#6964
Rank
$0.40 B
Marketcap
$1.94
Share price
4.02%
Change (1 day)
117.98%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -$40.45 Million USD

According to Akebia Therapeutics's latest financial reports the company's current earnings are $0.17 Billion USD. In 2023 the company made an earning of -$51.93 Million USD, an increase over its 2022 earnings that were of -$94.62 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$40.45 Million-22.11%
2023 -$51.93 Million-45.12%
2022 -$94.62 Million-66.55%
2021 -$0.29 Billion-26.24%
2020 -$0.39 Billion33.94%
2019 -$0.29 Billion66.52%
2018 -$0.18 Billion123.53%
2017 -$76.92 Million-43.34%
2016 -$0.14 Billion123.58%
2015 -$60.72 Million63.95%
2014 -$37.04 Million181.24%
2013 -$13.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$4.67 B-11,669.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.73 B-31,582.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$18.39 B-45,584.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.18 Billion 338.06%๐Ÿ‡บ๐Ÿ‡ธ USA